Jenelle Robinson
Obstetrics & Gynecology · Milledgeville, GANPI 1841697711
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,284 of the $1,601 with a category attached, or 80.2%. 22 manufacturers reported payments, led by Amgen at 27.1% of the total. Reporting peaked in 2019 at $834 and has fallen 86.8% since, to $110 in 2023.
Across 61 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$434
- Celularity Inc.$300
- AbbVie$163
- Exeltis, USA Inc.$87
- Mayne Pharma Commercial LLC$80
- Davol Inc.$76
- plus $461 from 16 others
What the payments were for
- Speaking & faculty fees$30019%
- Food & beverage$1,28480%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 17 | $434 |
| Celularity Inc. | 1 | $300 |
| AbbVie(2 entities) | 10 | $163 |
| Exeltis, USA Inc. | 4 | $87 |
| Mayne Pharma Commercial LLC | 3 | $80 |
| Davol Inc. | 1 | $76 |
| Roche Diagnostics Corporation | 2 | $69 |
| Lupin Inc. | 4 | $69 |
| Therapeuticsmd, Inc. | 3 | $57 |
| Pfizer | 2 | $37 |
| Myovant Sciences Inc. | 2 | $29 |
| Organon | 1 | $27 |
| Minerva Surgical, Inc | 2 | $24 |
| Coopersurgical, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$125
How this compares
$1,601 in reported general payments places this provider in the 65th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClimaraEstradiol | 13 | $651 |
| Estradiol | 13 | $345 |
| Fluconazole | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerClimara | $18 | $65113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Milledgeville
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
- Christopher BassilSuwanee$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.